Boston Scientific Corporation
BSX · Healthcare · · USDFahodi Score STRONG SELL Short-term (Swing)
25
/ 100
Technical
25
Trend & RS
22
Momentum
24
Fundamental (0%)
70
Macro
24
Liquidity
38
| Component | Score | Weight |
|---|---|---|
| Technical | 25.0 | 40% |
| Trend & RS | 22.0 | 20% |
| Momentum | 23.9 | 20% |
| Fundamental | 70.4 | 0% |
| Macro | 23.8 | 15% |
| Liquidity | 38.0 | 5% |
Trade Setup
| Entry | 43.24 |
| Stop Loss | 39.70 (8.2%) |
| Target 1 (1:1) | 46.78 (+8.2%) |
| Target 2 (2:1) | 50.33 (+16.4%) |
| ATR(14) | 1.77 (4.1%) |
| Risk per Share | 3.54 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 69.4 | +0.78 | |
| Momentum | 23.9 | -1.05 | |
| Quality | 42.1 | -0.32 | |
| Composite | 45.1 | ||
Quality Scores
Piotroski F-Score
5
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
4.26
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 18.2 | 22.0 | -17% below |
| P/B Ratio | 2.4 | 4.0 | Below |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
29.26
vs
Market Price
43.22
Upside
-32.3%
| Margin of Safety | -47.7% |
| Stage 1 PV (5yr FCF) | 11,309,699,908 |
| Terminal Value PV | 31,097,638,256 |
| Total Enterprise Value | 42,407,338,164 |
Assumptions
| Base FCF | 2,748,201,229 |
| Growth Rate (5yr) | 2.0% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
10.75%
Full Kelly
5.38%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 25/100. Estimated win rate 47%, avg win 6.5%, avg loss 4.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG SELL
1
Bullish Signals
3
Bearish Signals
46.44
RSI(14)
-0.0858
MACD
Relative Strength (RS) WEAK RS
5
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (-9.3% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | No (56d since high) |
| Sector Outperformance | -23.4% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
WEAK RS:
Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 46.44 | NEUTRAL |
| Macd | -0.0858 | BULLISH |
| Ma Cross | 44.34 / 55.36 | DEATH CROSS |
| Trend Short | BELOW SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 105.65 |
| Bollinger Upper | 46.66 |
| SMA(200) | 55.36 |
| SMA(50) | 44.34 |
| SMA(20) | 44.24 |
| Current Price | 43.22 |
| Bollinger Lower | 41.82 |
| 52-Week Low | 39.57 |
| ATR(14) | 1.77 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKDOWN
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 0.0 |
Markdown: 2.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 1.16x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.96x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.76x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.15x | Normal bar — no special VSA pattern |
| 2026-11-06 | Normal | 0.02x | Normal bar — no special VSA pattern |
Ichimoku Cloud BEARISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 43.27 | Below Kijun |
| Kijun-sen (26) | 43.27 | Base line |
| Senkou A | 43.27 | Leading span A |
| Senkou B | 44.61 | Leading span B |
| Cloud | 43.27 – 44.61 | Bearish (Red) |
| Price vs Cloud | 43.24 | Below Cloud |
| Chikou Span | 42.60 | Bullish |
| Alignment Score | 1/4 | BEARISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
2 bars
Momentum:
BEARISH
BB: 41.82 – 46.66 | KC: 41.62 – 46.86
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Hidden Bullish | MACD | 6 |
Anchored VWAP
VWAP: 43.31
Anchor: 2026-10-28 (52w Low)
BELOW AVWAP
-0.2%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/BSX
Valuation
| Metric | Value |
|---|---|
| Market Cap | 62.64B |
| P/E (TTM) | 18.24 |
| Forward P/E | N/A |
| P/B | 2.44 |
| EPS | 2.37 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 1.4% |
| Profit Margin | 16.6% |
| ROE | 14.1% |
| Debt/Equity | 46.20 |
| Current Ratio | 1.36 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 0.58 |
Trading Data
43.22
Open
43.22
Day High
43.22
Day Low
900.0K
Volume (0.0x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)